Blueshift Asset Management’s Inspire Medical Systems INSP Stock Holding History

Blueshift Asset Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,717	Closed	-$230K	–	417
2024 Q2	$230K	Buy	+1,717	New	+$325K	0.08%	298
2023 Q2	–	Sell	-1,581	Closed	-$370K	–	409
2023 Q1	$370K	Buy	+1,581	New	+$400K	0.15%	189
2022 Q3	–	Sell	-1,872	Closed	-$342K	–	727
2022 Q2	$342K	Buy	1,872 +75	+4%	+$15K	0.06%	409
2022 Q1	$461K	Buy	+1,797	New	+$411K	0.04%	477
2021 Q4	–	Sell	-3,235	Closed	-$753K	–	1033
2021 Q3	$753K	Buy	+3,235	New	+$675K	0.04%	495
2020 Q3	–	Sell	-9,955	Closed	-$866K	–	681
2020 Q2	$866K	Buy	+9,955	New	+$765K	0.14%	209
2019 Q4	–	Sell	-3,439	Closed	-$210K	–	899
2019 Q3	$210K	Buy	+3,439	New	+$226K	0.03%	625

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Blueshift Asset Management's INSP Position: Q3 2024 in Review

Blueshift Asset Management sold out of Inspire Medical Systems (INSP) in Q3 2024, closing a stake of 1,717 shares — an estimated $230K sold.

Blueshift Asset Management first reported a position in INSP in Q3 2019 and held it in 7 quarters. The position peaked at $866K in Q2 2020. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.

Blueshift Asset Management reported no remaining Inspire Medical Systems position as of Q3 2024 after selling out during the quarter.
Blueshift Asset Management sold 1,717 Inspire Medical Systems shares in Q3 2024, an estimated $230K.
Blueshift Asset Management first reported a position in Inspire Medical Systems in Q3 2019 and held it in 7 quarters.
Blueshift Asset Management's Inspire Medical Systems position peaked at $866K in Q2 2020.
346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.

Based on Blueshift Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.